These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19999176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treating osteoporosis.
    Smith G, Stassen L, Flint S.
    Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N.
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Osteonecrosis of the jaw & osteoporosis therapy.
    Kessenich CR.
    Nurse Pract; 2010 Jul; 35(7):51-3. PubMed ID: 20555246
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
    Thompson E, Sheehy C, Barry M, Carey J.
    Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
    [No Abstract] [Full Text] [Related]

  • 10. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R.
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diabetes and the risk of osteonecrosis of the jaw.
    Favus MJ.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):817-8. PubMed ID: 17341579
    [No Abstract] [Full Text] [Related]

  • 13. Bisphosphonate treatment as a cause of jaw osteonecrosis.
    Kanat O, Ozet A, Ataergin S, Kuzhan O, Arpaci F, Ozturk B, Komurcu S, Ozturk M.
    Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221
    [No Abstract] [Full Text] [Related]

  • 14. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial SurgeonsAAOMS, Rosemont, IL 60018, USA..
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract] [Full Text] [Related]

  • 15. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis).
    Grana J, Mahia IV, Meizoso MO, Vazquez T.
    Clin Exp Rheumatol; 2008 Nov; 26(2):384-5. PubMed ID: 18565271
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.